TriHealth

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, TriHealth sits in the top decile of US sponsors by registered trial count (#277 of 15,742 sponsors by registered trial count).

81 total trials 2 currently recruiting 62 completed later-stage tilt top decile by trial count

TriHealth: 81 sponsored US clinical trials, 2 recruiting.

TriHealth sponsors 81 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 62 completed. 13 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Resected Polyp, with 1 trials.

Top-decile sponsor footprint

TriHealth ranks in the top decile of sponsors by registered trial count (#277 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 43/100

62 of 76 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

81 total, page 2 of 2

COMPLETED Phase 4

Improvement of Pain Following Robotic Sacrocolpopexy and Rectocele Repair for Pelvic Organ Prolapse

NCT02449915

TERMINATED Phase 1

Probiotics in the Reduction of Antibiotic Associated Diarrhea

NCT02589964

TERMINATED Phase 4

Impact of Liposomal Bupivacaine Administered Following Placement of a Transobturator Suburethral Sling

NCT02591888

TERMINATED

Targeted Intraoperative Therapy Registry at Bethesda North Hospital (TARGIT)

NCT02364960

COMPLETED Phase 4

Trial Liposomal Bupivacaine Following Retropubic Suburethral Sling for Stress Urinary Incontinence

NCT02296099

TERMINATED NA

Efficacy of Linaclotide to Senna for CIC

NCT02239510

COMPLETED NA

Effective Pain Management of Interscalene Blocks During Shoulder Surgery

NCT02267044

COMPLETED NA

Use of Peanut Labor Ball Following Epidural Anesthesia

NCT02190591

COMPLETED NA

Multimodal DVT Protocol in Tourniquet-less Total Knee Arthroplasty

NCT02102828

COMPLETED NA

Delayed Clamping and Milking the Umbilical Cord in Preterm Infants

NCT02092103

TERMINATED NA

Oxybutynin and Omega-3 for OAB (Overactive Bladder)

NCT02070042

COMPLETED

Difference in Pain, Quality of Life Following Vaginal Hysterectomy With Vaginal Reconstruction Versus Robotic Colpopexy?

NCT02049996

COMPLETED Phase 4

RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Operative Vaginal Reconstruction Pain

NCT02043704

COMPLETED Phase 4

RCT (Randomized Controlled Trial) of IV Acetaminophen for Post Cesarean Pain Relief

NCT02046382

TERMINATED NA

Measuring Pain and Hydration After Tonsillectomy

NCT02011230

COMPLETED Phase 3

Effects of Preoperative Dexamethasone Study on QOL After Vaginal Reconstructive Surgery for POP

NCT02073734

COMPLETED NA

Acupuncture for Sexual Dysfunction

NCT02070029

COMPLETED NA

Maintaining Patency in Implanted Port Catheters

NCT02354118

COMPLETED NA

Does Vaginal Packing Influence Patient Outcomes Following Vaginal Reconstructive Surgery?

NCT02000271

COMPLETED NA

Gomco Versus Mogen: Which is Best? A Randomized Controlled Trial

NCT01726036

COMPLETED NA

Physical Therapy for Women With Obstetric Trauma and Anal Incontinence

NCT01672697

COMPLETED

Systemic Markers of Collagen Metabolism and Vitamin C in Smokers and Non-Smokers With Pelvic Organ Prolapse

NCT01548105

COMPLETED NA

Diazepam Vaginal Suppositories for High Tone Pelvic Floor Dysfunction.

NCT01233791

COMPLETED NA

Patient Satisfaction and Pain Control Following Reconstructive Vaginal Surgery

NCT01442818

COMPLETED Phase 2

A Comparison of Metallic Staples Versus Absorbable Staples After a Cesarean Section (C-Section)

NCT01198691

COMPLETED

Clitoral Location in Relation to Sexual Function Using Pelvic Imaging

NCT01195701

COMPLETED NA

Physical Therapy on Quality of Life and Function Following Vaginal Surgery Reconstructive Surgery

NCT01403701

COMPLETED

Fetal Lung Maturation in Twin Gestations

NCT01385267

COMPLETED NA

Bowel Preparation and Pelvic Organ Prolapse Surgery

NCT00937430

COMPLETED Phase 3

The Effects of Local Vaginal Estrogen in Postmenopausal Women With Pelvic Organ Prolapse

NCT00803335

COMPLETED NA

Virtual Reality Laparoscopy Training

NCT01184950

← Previous Page 2 of 2

Where TriHealth enrollment is open (later-stage tilt)

2 recruiting of 81 indexed (2% open); 62 completed (77%).

Phase mix: 13 late (III/IV) vs 5 early (I/II) (later-stage heavy).

Top condition: Resected Polyp (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

TriHealth: open-pipeline peers nationwide

Peers matched on 81 registered trials and 2% open enrollment, not the therapeutic-area sidebar.

TriHealth sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 30405060708090 0%5%10%15%20%25% Total trials Recruiting share TriHealthEMD Serono Research & Development InstituteThe University of Tennessee, KnoxvilleChristiana Care Health ServicesUCB Biopharma SRLChildren's Healthcare of AtlantaHarvard School of Public Health (HSPH)Ethicon Endo-SurgeryCumberland Pharmaceuticals
TriHealth sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

TriHealth sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 81 trials (± recruiting share)

Sponsors near 2% open enrollment (± trial volume)

What to do with this TriHealth page

81 registered trials is a research-attention snapshot, not an endorsement of TriHealth or any single study.

  • 2 of TriHealth's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Resected Polyp is the condition TriHealth studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Resected Polyp trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

TriHealth pipeline card: 81 registered trials from official public datasets.Report a data error.